Celator Pharmaceuticals to Begin Trading on NASDAQ on Monday, November 11, 2013

Celator Pharmaceuticals

today announced that its common stock has been approved for listing on the NASDAQ Capital Market and is expected to begin trading on Monday, November 11, 2013 under the symbol CPXX. The company's common stock will continue to trade on the Over the Counter Bulletin Board, under the symbol CLPM, until the market close on Friday, November 8, 2013. "This is an important milestone to Celator's success as a public company," said Scott Jackson, chief executive officer of Celator Pharmaceuticals. "We believe that listing with NASDAQ will raise awareness of the company with the investment community and help increase our liquidity."